Those who showed ‘sub-optimal’ response to cholesterol-lowering drugs also 22% more likely to develop heart disease
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, new research suggests.
Guidelines from the National Institute for Health and Care Excellence (Nice) aim for a 40% or more reduction in low density lipoprotein cholesterol from the treatment.
This post was syndicated from Health | The Guardian. Click here to read the full text on the original website.